Kaisa Health Sets 25 Aug 2026 Board Meeting to Approve 1H26 Results and Consider Interim Dividend
Bulletin Express
Aug 13
Kaisa Health Group Holdings Limited will convene its board of directors on 25 August 2026 to review and approve the consolidated interim results for the six months ended 30 June 2026. The agenda also includes deliberation on a potential interim dividend.
The meeting notice, signed by Chairman Kwok Ying Shing, was released on 13 August 2026 in Hong Kong. The Board currently comprises six executive directors—Kwok Ying Shing, Luo Jun, Luo Tingting, Xie Binhong, Yang Feng and Ye Haoda—along with three independent non-executive directors: Liu Yanwen, Lyu Aiping and Li Zhiying.
Publication of the interim results and any dividend decision will follow the Board’s approval on the scheduled date.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.